Lupin Limited Share Price & Technical Analysis
LUPIN · ₹2,287 (+0.24%)
Healthcare / Drug Manufacturers - Specialty & Generic
₹2,287
+0.24%
Lupin Limited, together with its subsidiaries, operates as a pharmaceutical company in India, the United States, and internationally. The company operates in two segments: Pharmaceuticals and Others. It engages in the drug discovery, development, production, marketing, and sale of various branded and generic formulations, biosimilars, over-the-counter and specialty drugs, and active pharmaceutical…
Price chart
Seasonality
May has 1 positive and 4 negative years (last 5 years shown)
-1% return in May, 1% avg return in past 3 year May month.
9% return in 2026, 37% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | 2% | 8% | 2% | -2% | -1% | – | – | – | – | – | – | – | 9% |
| 25 | -12% | -7% | 7% | 4% | -6% | -1% | -1% | -2% | 1% | 2% | 6% | 1% | -8% |
| 24 | 14% | 7% | 0% | 0% | -4% | 0% | 18% | 17% | -3% | 0% | -7% | 15% | 57% |
| 23 | 0% | -11% | -1% | 9% | 13% | 12% | 9% | 11% | 7% | -4% | 13% | 3% | 63% |
| 22 | -5% | -19% | 1% | 0% | -16% | -2% | 5% | 3% | 2% | 3% | 9% | -4% | -23% |
Monthly return % by calendar month · historical pattern, not a forecast
Bearish · Emerging · Neutral
Lupin Limited, together with its subsidiaries, operates as a pharmaceutical company in India, the United States, and internationally. The company operates in two segments: Pharmaceuticals and Others. It engages in the drug discovery, development, production, marketing, and sale of various branded and generic formulations, biosimilars, over-the-counter and specialty drugs, and active pharmaceutical ingredients (APIs). The company also offers formulations for use in the therapeutic areas of anti-tuberculosis, diabetes management, cardiovascular, chronic obstructive pulmonary diseases, asthma, women's health, and central nervous system areas, as well as pediatrics, gastrointestinal, anti-infective, and nonsteroidal anti-inflammatory drug therapies. In addition, it focuses on various therapeutic spectrum, including rheumatology, oncology, neuroscience, and renal therapies. Further, the company is involved in the provision of diagnostics services, and digital healthcare services; and neuro rehabilition business. It operates through network consists of labs and collection centers. The company has a strategic collaboration with TB Alliance for the development and commercialization of the investigational drug Telacebec for the treatment of multiple mycobacterial diseases including tuberculosis (TB), leprosy, and buruli ulcer. The company was formerly known as Lupin Chemicals Limited and changed its name to Lupin Limited in 2001. Lupin Limited was founded in 1968 and is headquartered in Mumbai, India.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
₹1.03T
P/E ratio
19.29
52W high
₹2,494
52W low
₹1,837
Volume
7,73,724
Beta
0.23
Related stocks in Healthcare
Ngl Fine-chem Ltd.
₹2,260
Frequently asked questions
- What is Lupin Limited share price today?
- Lupin Limited (LUPIN) last traded around ₹2,287 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does LUPIN have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for LUPIN. Download the app for real-time alerts.
- How can I analyze Lupin Limited stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.